SEC Form 3 · accession 0001179110-16-018330
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. Keith Joung
10% Owner
Period of report
Feb 2, 2016
Accepted (ET)
Feb 2, 2016 · 6:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001650664
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | holding | — | — | — | 480,769 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $6.48 | holding | — | — | — | — | Sep 13, 2025 | Common Stock | 96,153 | — | D |
Explanation of responses
- F1These shares are restricted stock owned by MMK Tech LLC ("MMK") and issued pursuant to a restricted stock agreement between the Issuer and MMK. Twenty-five percent of the shares vested on November 21, 2013, and the remainder are scheduled to vest in equal monthly installments from August 1, 2013 until August 1, 2017.
- F2The shares are held directly by MMK. The sole managing member of MMK is the Jae Keith Joung 2007 Revocable Trust (the "Trust"). J. Keith Joung is a trustee of the Trust and therefore may be deemed to beneficially own the shares held by MMK.
- F3This option was granted on September 14, 2015 and is scheduled to vest over four years with the shares scheduled to vest in equal quarterly installments beginning on December 10, 2015.